首页> 外文期刊>Journal of Internal Medicine >Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study.
【24h】

Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study.

机译:可溶性尿激酶型纤溶酶原激活剂受体的血浆水平可作为细菌血症患者疾病严重程度和病死率的预测指标:一项前瞻性队列研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract. Huttunen R, Syrjanen J, Vuento R, Hurme M, Huhtala H, Laine J, Pessi T, Aittoniemi J (Tampere University Hospital; University of Tampere Medical School, University of Tampere; Centre for Laboratory Medicine, Pirkanmaa Hospital District; University of Tampere Medical School; School of Health Sciences, University of Tampere; and Medical School, University of Tampere; Tampere, Finland) Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study. J Intern Med 2011; 270: 32-40. Objectives. Urokinase-type plasminogen activator receptor (uPAR) is expressed on a variety of different immune cells and vascular endothelial cells during inflammation. Previous studies indicate that a high plasma concentration of the soluble form of the receptor (suPAR) predicts poor outcome in infectious diseases. Design. A prospective cohort study. Subjects and methods. Plasma suPAR levels were measured in 132 patients with bacteraemia caused by Staphylococcus aureus, Streptococcus pneumoniae, ss-haemolytic streptococcae or Escherichia coli using a commercial enzyme-linked immunosorbent assay (ELISA). Values were measured on days 1-4 after a positive blood culture, on days 13-18 and on recovery. Results. The maximum suPAR values on days 1-4 were markedly higher in nonsurvivors compared to survivors (15.8 vs. 7.3 ng mL(-1) , P < 0.001) and the area under the receiver operating characteristic curve (AUC(ROC) ) in the prediction of case fatality was 0.84 (95% confidence interval (CI) 0.76-0.93, P < 0.001). At a cut-off level of 11.0 ng mL(-1) , the sensitivity and specificity of suPAR for fatal disease was 83% and 76%, respectively. A high level of suPAR (>/=11 ng mL(-1) ) was associated with hypotension (mean arterial pressure <70 mmHg) (odds ratio (OR) 6.5; 95% CI 2.9-14.6) and high sequential organ failure assessment score (>/=4) (OR 9.3; 95% CI 4.0-21.9). A high suPAR level remained an independent risk factor for case fatality in a logistic regression model adjusted for potential confounders. Conclusion. Plasma suPAR level is a sensitive and specific independent prognostic biomarker in patients with bacteraemia.
机译:抽象。 Huttunen R,Syrjanen J,Vuento R,Hurme M,Huhtala H,Laine J,Pessi T,Aittoniemi J(坦佩雷大学医院;坦佩雷大学坦佩雷医学院;坦佩雷大学皮尔肯玛医院区检验医学中心;坦佩雷大学医学院;坦佩雷大学健康科学学院;坦佩雷大学医学院;芬兰坦佩雷)可溶性尿激酶型纤溶酶原激活物受体的血浆水平可作为细菌血症患者疾病严重程度和病死率的预测指标队列研究。 J Intern Med 2011; 270:32-40。目标。在炎症过程中,尿激酶型纤溶酶原激活剂受体(uPAR)在多种不同的免疫细胞和血管内皮细胞上表达。先前的研究表明,血浆可溶性受体(suPAR)的浓度较高,预示着传染病的预后不良。设计。一项前瞻性队列研究。主题和方法。使用商业酶联免疫吸附试验(ELISA)对132例由金黄色葡萄球菌,肺炎链球菌,ss溶血性链球菌或大肠杆菌引起的菌血症患者的血浆suPAR水平进行了测量。在阳性血液培养后第1-4天,第13-18天和恢复时测量值。结果。与幸存者相比,非幸存者在1-4天的最大suPAR值显着更高(15.8 vs. 7.3 ng mL(-1),P <0.001),并且接受者工作特征曲线下的面积(AUC(ROC))显着高于幸存者。病例死亡的预测值为0.84(95%置信区间(CI)为0.76-0.93,P <0.001)。临界水平为11.0 ng mL(-1)时,suPAR对致命疾病的敏感性和特异性分别为83%和76%。高水平的suPAR(> / = 11 ng mL(-1))与低血压(平均动脉压<70 mmHg)(比值比(OR)6.5; 95%CI 2.9-14.6)和高顺序器官衰竭评估相关得分(> / = 4)(或9.3; 95%CI 4.0-21.9)。在针对潜在混杂因素进行调整的逻辑回归模型中,高suPAR水平仍然是导致病例死亡的独立风险因素。结论。血浆suPAR水平是菌血症患者的敏感且特异的独立预后生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号